Thymosin Alpha-1

What is Thymosin Alpha-1?

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid peptide originally isolated from thymic tissue. It is N-terminally acetylated and circulates in human plasma. Tα1 is one of the few research peptides with regional regulatory approval as a therapeutic (e.g., Zadaxin in some countries) but is supplied here strictly for laboratory research.

Mechanism of action (preclinical evidence)

Thymosin Alpha-1 (Tα1) acts primarily as an immunomodulatory peptide signaling through Toll-like Receptor 9 (TLR-9), which is expressed on dendritic cells, B-lymphocytes, and certain T-cell subpopulations. TLR-9 engagement activates the MyD88 adapter and downstream NF-κB and IRF7 transcription factors, leading to a Th1-biased cytokine profile (IFN-γ, IL-2) and downregulation of pro-inflammatory Th17 responses. The net effect in preclinical models is enhanced T-cell maturation - specifically increased CD4+ and CD8+ effector function and improved antigen presentation by dendritic cells. This mechanism differs from immunostimulants that act through cytokine cocktails or receptor agonism on a single cell type; Tα1's action is more upstream, modifying how the immune system perceives and responds to antigens. Published data also describe Tα1 effects on NK cell activity, monocyte function, and on the balance between Th1 and regulatory T-cell (Treg) populations. The peptide does not appear to directly stimulate antibody production. In immunocompromised models (HIV, chemotherapy-induced immunosuppression, elderly populations), the restoration of TLR-9-driven dendritic cell function appears to underlie the observed improvements in vaccine response and pathogen clearance. The mechanism is dose-dependent and time-sensitive: TLR-9 desensitizes with chronic exposure, which is why most preclinical and clinical regimens use intermittent rather than continuous administration.

Research applications

• T-cell maturation and thymopoiesis models
• Innate immunity studies (TLR signaling)
• Dendritic cell differentiation research
• Cytokine response profiling (Th1/Th2/Treg balance)
• Antiviral and tumor immunology preclinical models

Storage and handling

Store the lyophilised vial at -20 °C, sealed and protected from light. Reconstituted Tα1 should be aliquoted and used promptly; 28-amino-acid peptides are sensitive to aggregation under repeated freeze-thaw.

Regulatory status

Tα1 is approved as a medicine in some jurisdictions (e.g., Zadaxin/thymalfasin) but is supplied by Peptra Labs strictly as a research-grade compound. Verify local regulatory and import requirements.

Frequently asked questions